- Home
- SABS vs LIQT Comparison
SABS vs LIQT Comparison
Compare SABS & LIQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- LIQT
- Stock Information
- Founded
- SABS 2014
- LIQT 2004
- Country
- SABS United States
- LIQT Denmark
- Employees
- SABS N/A
- LIQT N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- LIQT Industrial Machinery/Components
- Sector
- SABS Health Care
- LIQT Technology
- Exchange
- SABS Nasdaq
- LIQT Nasdaq
- Market Cap
- SABS 15.8M
- LIQT 16.1M
- IPO Year
- SABS N/A
- LIQT N/A
- Fundamental
- Price
- SABS $2.64
- LIQT $1.80
- Analyst Decision
- SABS Strong Buy
- LIQT Strong Buy
- Analyst Count
- SABS 5
- LIQT 2
- Target Price
- SABS $11.80
- LIQT $4.80
- AVG Volume (30 Days)
- SABS 35.3K
- LIQT 30.5K
- Earning Date
- SABS 08-07-2025
- LIQT 08-13-2025
- Dividend Yield
- SABS N/A
- LIQT N/A
- EPS Growth
- SABS N/A
- LIQT N/A
- EPS
- SABS N/A
- LIQT N/A
- Revenue
- SABS $377,835.00
- LIQT $14,986,815.00
- Revenue This Year
- SABS N/A
- LIQT $36.89
- Revenue Next Year
- SABS N/A
- LIQT $16.33
- P/E Ratio
- SABS N/A
- LIQT N/A
- Revenue Growth
- SABS N/A
- LIQT N/A
- 52 Week Low
- SABS $1.00
- LIQT $1.34
- 52 Week High
- SABS $5.01
- LIQT $3.20
- Technical
- Relative Strength Index (RSI)
- SABS 77.22
- LIQT 62.68
- Support Level
- SABS $1.72
- LIQT $1.74
- Resistance Level
- SABS $2.72
- LIQT $1.84
- Average True Range (ATR)
- SABS 0.19
- LIQT 0.12
- MACD
- SABS 0.10
- LIQT 0.03
- Stochastic Oscillator
- SABS 91.89
- LIQT 81.47
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About LIQT LiqTech International Inc.
LiqTech International Inc is a clean technology company which provides technology for gas and liquid purification by manufacturing ceramic silicon carbide filters. The company is engaged in three businesses that are diesel particulate filters (DPF) for the control of soot from diesel engines, turnkey ceramic membranes systems, and complete water treatment plants. The company's product portfolio consists of ceramic silicon membranes for liquid filtration, diesel particulate filters, and kiln furniture. Its operating segment includes Water, Ceramics, and Plastics.